Miranda Cole
Feature‘Excessive pricing’ and pharmaceuticals
Alleged abuse of dominance through excessive pricing in the pharmaceutical sector could be curbed.
FeaturePay-for-delay rulings under appeal
Appeals have potentially significant ramifications for the upcoming Competition Appeal Tribunal hearings in the GSK paroxetine case.